Clinical trial
Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in…
NCT00426257 · The Netherlands Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00426257 |
|---|---|
| Title | Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer |
| Official title | Phase III Randomised Clinical Trial for Stage III Ovarian Carcinoma Randomising Between Secondary Debulking Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy |
| Lead sponsor | The Netherlands Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Procedure |
| Interventions | Secondary debulking, secondary debulking with intraperitoneal chemotherapy |
| Enrollment | 242 |
| Start date | Feb 1, 2007 |
| Primary completion | Aug 16, 2017 |
| Completion | Aug 16, 2017 |
| First posted | Jan 24, 2007 |
| Last update posted | Aug 24, 2018 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: